Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination D000068899

Related MeSH Hierarchy (4)

Chemicals and Drugs [D] » Heterocyclic Compounds [D03] » Heterocyclic Compounds, 1-Ring » Azoles » Triazoles » Sitagliptin Phosphate » Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination

Chemicals and Drugs [D] » Organic Chemicals [D02] » Amidines » Guanidines » Biguanides » Metformin » Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination

Chemicals and Drugs [D] » Heterocyclic Compounds [D03] » Heterocyclic Compounds, 1-Ring » Pyrazines » Sitagliptin Phosphate » Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination

Chemicals and Drugs [D] » Pharmaceutical Preparations [D26] » Drug Combinations » Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination

Description

A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.   MeSH

Hierarchy View

Hierarchy Tree View


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.